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A B S T R A C T   
Objective: Several risk factors for type 2 diabetes mellitus (T2DM) are also associated with blood concentrations 
of persistent organic pollutants (POPs), and factors related to the disease may affect POP concentrations, and 
subsequent associations between POPs and T2DM. The purpose of this pilot study was to investigate the change 
in concentrations of lipids, hormones and POPs pre- and post-diagnosis in T2DM cases compared to healthy 
controls and their associations with T2DM. 
Methods: We measured POPs, lipids, and thyroid and steroid hormones in plasma from 44 female cases collected 
prior to (pre-diagnostic) and following (post-diagnostic) T2DM diagnosis, and in 44 healthy female age-matched 
controls. We compared cross-sectional differences and longitudinal changes within and between matched cases 
and controls with t-tests and multivariable linear regression models. Associations between POP concentrations 
and T2DM were investigated using conditional logistic regression. 
Results: Between the pre- and post-diagnostic measurement, cases developed more favorable lipid profiles and the 
longitudinal changes in lipid-normalized concentrations of non-dioxin-like polychlorinated biphenyls (PCBs), 
dioxin-like PCBs, beta-hexachlorocyclohexane (HCH), HCB, and 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane 
(p,p’-DDE) differed significantly between cases and controls. The longitudinal changes in POPs were mainly 
driven by changes in bodyweight, total lipids and T2DM status. Cases had significantly higher pre-diagnostic 
concentrations of POPs and triglycerides, and lower concentrations of high-density lipoprotein cholesterol and 
free thyroxin than controls. Pre-diagnostic POP concentrations were not significantly associated with incident 
T2DM, whereas several post-diagnostic POP concentrations were significantly positively associated with prev-
alent T2DM. 
Conclusions: This pilot study suggests that factors related to T2DM affect blood concentrations of POPs and may 
partly explain the positive associations between POPs and T2DM.   
1. Introduction 
Chlorinated persistent organic pollutants (POPs) have received 
extensive attention due to their lipophilicity, persistency, and chronic 
toxicity in living organisms. A large number of epidemiological studies 
with cross-sectional or prospective designs (reviewed in Lee et al., 
2014), including our previous contribution (Rylander et al., 2015), have 
linked background exposure to POPs with type 2 diabetes mellitus 
(T2DM). Obesity is a well-known risk factor for T2DM, and people with 
obesity experience larger in vivo dilution of POPs in fat mass and slower 
degradation rates than normal-weight persons (Thomaseth and Salvan 
1998). As many POPs are lipophilic, weight change episodes can affect 
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POP concentrations in the blood through dilution or enrichment (De 
Roos et al., 2012). Further, individuals with T2DM often suffer from 
dyslipidemia, a condition that causes elevated lipid concentrations in 
the blood, which may affect circulating POP concentrations (Jansen 
et al., 2017). Accordingly, a number of physiological conditions asso-
ciated with T2DM are also associated with elevated POP concentrations 
and becomes a challenge when investigating the association between 
POPs and T2DM. If T2DM alters POP concentrations, measuring POP 
concentrations after disease onset will introduce bias due to factors 
related to the disease progression. Accordingly, studies have reported 
that individuals who develop T2DM have elevated concentrations of 
blood lipids and higher BMI, years before being diagnosed with T2DM 
(Hulsegge et al., 2017; Vazquez et al., 2007). In order to disentangle 
these complex relationships, longitudinal studies of POPs and T2DM 
with repeated measurements from the same individuals are needed (Lee 
et al., 2014). Such studies are costly and require large collections of 
prospective samples. To increase our knowledge we initiated this pilot 
study of pre- and post-diagnostic profiles of POPs, lipids, thyroid and 
steroid hormones, and body weight in T2DM cases and controls. The 
intention is to use the lessons learnt from this study in the design of 
larger, future, longitudinal studies of POPs and T2DM. 
2. Materials and methods 
2.1. Study sample 
The women included in the present study were participants of the 
Norwegian Women and Cancer (NOWAC) study (Lund et al., 2008). 
Details about the NOWAC study and procedures are published elsewhere 
(Lund et al., 2008; Waaseth et al., 2008). In brief, 7849 participants 
donated two blood samples: the first in 2001/02 and the second in 
2005/06. Fifty-three incident T2DM cases were identified between these 
time points from self-administered questionnaires, which included 
questions about diabetes, age at diabetes diagnosis, and use of glucose 
lowering drugs. Incident T2DM cases were defined as those who re-
ported no diabetes or age at diabetes diagnosis, and no use of glucose 
lowering drugs at or before 2001/02 and reported diabetes, age of 
diabetes diagnosis, and/or use of glucose lowering drugs in 2004/05. 
Participants reporting use of insulin only were considered to have type 1 
diabetes mellitus and were not considered as eligible T2DM cases. 
Self-reported diabetes in the NOWAC Study has been previously vali-
dated against medical journals/doctors confirmation (Rylander et al., 
2014). Of the 53 incident T2DM cases, 44 had blood samples available 
for 2001/02 (pre-diagnostic samples) and for 2005/06 (post-diagnostic 
samples). We randomly selected two, diabetes-free control groups: 
control group 1 was matched to T2DM cases on birth year ( ±1 year) and 
year of pre-and post-diagnostic blood sample collection; control group 2 
was matched on birth year ( ±1 year), BMI in 2005/06 ( ±3 kg/m2) and 
year of pre-and post-diagnostic blood sample collection. There were 
only 41 available controls that matched the cases both on birth year and 
BMI, thus case-control group 2 consisted of 41 matched pairs. To facil-
itate the dissemination in this report, we focus on case-control group 1 as 
both case-control groups showed comparable results and conclusions. 
Hereafter, when referring to cases and controls, that means case control 
group 1, unless other is specified. Thus, the final study sample comprised 
44 cases and 44 controls. In addition to donating two blood samples, the 
participants had completed five detailed questionnaires of varying 
length and degree of detail (Figure S1 in the Supplemental material). 
2.2. Chemical analyses 
2.2.1. Persistent organic pollutant analyses 
The methods applied for POP analyses have been previously 
described in detail (Huber et al., 2020). Briefly, a Freedom Evo 200 
(Tecan, Männedorf, Switzerland) liquid handling workstation was used 
for sample preparation. A 150 μL plasma sample was diluted prior to 
extraction and cleaned-up by automated solid phase extraction. The 
instrumental analyses of 13 polychlorinated biphenyls (PCB) congeners 
and 13 organochlorine pesticides (OCPs) (specified in the Supplemental 
material) were performed by gas chromatography atmospheric pressure 
ionization coupled to tandem mass spectrometers (Waters, Milford, MA, 
USA). Standard reference materials and blank samples were prepared 
alongside the plasma samples and demonstrated concentrations well 
within reference values and no contamination. The atmospheric pres-
sure ionization was conducted in positive mode under charge transfer 
conditions. The multiple reaction monitoring (MRM) mode with two 
specific transitions for the individual analytes was applied for detection 
on the mass spectrometers. Quantification was performed using Mas-
slynx and Targetlynx software (Version 4.1, Waters) and achieved by the 
internal-standard method with isotope-labeled compounds. 
2.2.2. Analyses of lipids and thyroid hormones 
Measurements of plasma concentrations of triglycerides, total 
cholesterol, high-density lipoprotein (HDL) cholesterol, low-density li-
poprotein (LDL) cholesterol, thyroid stimulating hormone (TSH), free 
triiodothyronine (FT3) and free thyroxin (FT4) were performed on a 
Cobas® 8000 platform (Roche Diagnostics, Rotkreuz, Switzerland) by 
laboratory staff at the University Hospital of North Norway, Department 
of Laboratory Medicine. The laboratory is certified according to ISO 
151189 (Accreditation 2020). Quality controls are run at three different 
concentrations every day, and the laboratory also participates in the 
external quality assessment program, Lab Quality (Labquality 2020). 
Total lipids were calculated according to the formula proposed by Phi-
lips et al.: Total lipids = 2.27*total cholesterol + triglycerides +0.623 
(g/L) (Phillips et al., 1989). 
2.2.3. Analyses of steroid hormones 
A detailed sample procedure and information about chemicals, in-
ternal standards, quality controls, calibrators, mass spectrometry mode, 
and MRM transitions are included in the Supplemental material. Briefly, 
a Freedom Evo 200 (Tecan) liquid handling workstation was used for 
sample preparation. Concentrations of testosterone, 11-deoxycortisol, 
corticosterone, androstenedione, cortisol, and dehydroepiandrosterone 
sulfate (DHEA-S) were measured in the samples by LC-ESI-MS/MS using 
a Waters Acquity™ I-class UPLC system with an autosampler and a bi-
nary solvent delivery system (Waters), interfaced to a Waters Xevo TQ-S 
benchtop tandem quadrupole mass spectrometer (Waters, Manchester, 
UK). All calibration curves for the steroids were linear (r2 ≥ 0.99). 
2.3. Statistical analyses 
POPs with detection frequencies equal to or above 90% were eval-
uated in the statistical models. Concentrations below the limit of 
detection (LOD) were replaced by LOD/√2. POP concentrations were 
lipid-normalized by dividing wet weight concentrations by the total 
lipid concentrations. We used one-sample t-tests to test whether pre- and 
post-diagnostic differences in demographics, POP, lipid, and hormone 
concentrations between matched case-control pairs, differed from zero. 
One sample t-test were also used to assess mean intra-individual longi-
tudinal changes in POP, lipid, and hormone concentrations and body 
weight as well as comparison of longitudinal trends between cases and 
controls (longitudinal change in cases-longitudinal changes in controls). 
In order to control for confounding factors, we used linear regression 
models with the longitudinal changes in POP, lipid, and hormone con-
centrations and body weight as dependent variables, and T2DM status, 
age, pre-diagnostic BMI, and concurrent changes in weight, lipids (for 
POPs and hormones) and intake of seafood as independent variables. 
There were no changes in breastfeeding or parity between the two 
timepoints, so these variables were not included. 
We used conditional logistic regression models to study associations 
between pre- and post-diagnostic POP concentrations and T2DM status. 
The models included lipid-normalized concentrations of POPs and the 
V. Berg et al.                                                                                                                                                                                                                                     
Environmental Research 195 (2021) 110846
3
covariates BMI, weight change, breastfeeding, intake of seafood and 
total lipids. To determine which covariates to include in the regression 
models, we drew a directed acyclic graph (DAG). A presentation of the 
DAG and a description of the assumptions behind the DAG are presented 
in the Supplementary material (Figure S2). Results are presented as odds 
ratios (ORs) with 95% confidence intervals (CIs). All included variables 
were modelled as continuous exposure metrics. The statistical analyses 
were performed in STATA (v 16.1, StataCorp LLC). All p-values were 
two-sided, and a 5% level of significance was used. 
3. Results 
Mean time between the collection of pre- and post-diagnostic blood 
samples was 4 years. At the time of pre-diagnostic blood sample 
collection, mean age was similar for cases and controls (52 years), 
whereas cases were heavier (78 versus 72 kg) and had a higher BMI (29 
versus 26 kg/m2) compared to the controls (Table S1 in the Supple-
mental material). At the time of post-diagnostic blood sample collection, 
cases were heavier (80 versus 74 kg) and had a higher BMI (29 versus 27 
kg/m2) compared to the controls. There were no significant differences 
in parity, months of breastfeeding or intake of seafood between cases 
and controls at either time points (Table S1). Both cases and controls 
increased their body weight significantly from enrollment in NOWAC in 
1991 until last follow-up in 2005/06 (+6.4 kg and +8.7 kg, respec-
tively). Cases increased the most (+4.7 kg) in the period before the pre- 
diagnostic blood sample collection, whereas controls increased the most 
in the period between the pre- and the post-diagnostic blood sample 
collection (Table S2). 
T2DM cases had significantly higher pre-diagnostic concentrations of 
total lipids and triglycerides, and significantly lower HDL cholesterol 
and FT4 compared to controls (Fig. 1). Post-diagnostic concentrations of 
triglycerides were significantly higher in T2DM cases than in controls 
and, they had significantly lower total cholesterol, LDL cholesterol and 
HDL cholesterol. There were no other differences in hormone concen-
tration between cases and matched controls at any time point. In cases, 
concentrations of total lipids, triglycerides, total cholesterol, and LDL 
cholesterol decreased significantly from pre- to post-diagnostic blood 
sample collection, whereas HDL cholesterol and FT4 increased signifi-
cantly (Fig. 1). Among the controls, HDL-cholesterol significantly 
increased and DHEA-S decreased over that same time period. Concen-
trations of cortisol and corticosterone decreased in both cases and 
controls. There were significant differences in crude longitudinal 
changes in total lipid, triglyceride, and total cholesterol and FT4 con-
centrations between cases and controls (Fig. 1). When adjusting for 
confounding factors the differences remained significant (Table S3). 
T2DM cases had significantly higher pre- (trans-nonachlor, p,p′-DDE 
and p,p′-DDT) and post-diagnostic (PCBs, trans-nonachlor, p,p′-DDE, and 
p,p′-DDT) concentrations of several POPs, and significantly lower pre- 
diagnostic concentrations of ɣ-HCH compared to the controls (Fig. 2 
and Table S4). Wet weight concentrations of POPs displayed the same 
Fig. 1. Lipid and hormone concentrations in cases (red boxes) and controls (blue boxes) at T1 (year 2001/02, pre-diagnosis) and T2 (year 2005/06, post-diagnosis) 
and the crude longitudinal change in means (represented by lines). Boxes represent the 25th–75th percentiles, horizontal lines represent the median, dots represent 
the mean, whiskers indicate 1.5 times the length of the interquartile range above and below the 75th and 25th percentiles. * denotes significant difference in mean 
concentrations between cases and controls; þ denotes significant longitudinal change within the group; ■ denotes significant difference in longitudinal change 
between cases and controls. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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overall differences as the abovementioned lipid-normalized results 
(Figure S3). In cases, lipid-normalized PCB and HCB concentrations 
increased significantly from pre- to post-diagnostic blood sample 
collection (Fig. 2), whereas there were no significant differences in the 
other measured POPs. In comparison, wet weight concentrations of HCB 
increased significantly and concentrations of β-HCH and p,p′-DDT 
decreased, whereas there were no differences over time in wet weight 
concentrations of the other measured POPs (Figure S3). In controls, 
Fig. 2. POP concentrations in cases (red boxes) and controls (blue boxes) at T1 (year 2001/02, pre-diagnosis) and T2 (year 2005/06, post-diagnosis) and the crude 
longitudinal change in means (represented by lines). Boxes represent the 25th–75th percentiles, horizontal lines represent the median, dots represent the mean, 
whiskers indicate 1.5 times the length of the interquartile range above and below the 75th and 25th percentiles. * denotes significant difference in mean concen-
trations between cases and controls; þ denotes significant intra-individual longitudinal change; ■ denotes significant difference in longitudinal change between 
cases and controls. 
∑
NDL-PCBs: sum of non-dioxin like polychlorinated biphenyls includes PCB-28, 52, 74, 99, 153, 138, 170, 180, 187 and 194; 
∑
DL-PCBs: sum of 
dioxine-like polychlorinated biphenyls includes PCB-118 and 156; ɣ-HCH: gamma-hexachlorocyclohexane; β-HCH: beta-hexachlorocyclohexane; HCB: hexa-
chlorobenzene; p,p’-DDE: 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane; p,p’-DDT: 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane. (For interpretation of the ref-
erences to colour in this figure legend, the reader is referred to the Web version of this article.) 
Fig. 3. Odds ratios and 95% confidence intervals (CIs) for the associations between one interquartile range increase in lipid-normalized persistent organic pollutant 
(POP) concentrations and incident (T1, pre-diagnosis) and prevalent (T2, post-diagnosis) type 2 diabetes mellitus. 
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lipid-normalized and wet weight p,p′-DDE, p,p′-DDT and cis-nonachlor 
concentrations decreased significantly from pre- to post-diagnostic 
blood sample collection. The crude longitudinal changes in lipid- 
normalized NDL-PCBs, DL-PCBs, β-HCH, HCB, and p,p′-DDE were 
significantly different in cases compared to controls (Fig. 2). When 
adjusting for confounding factors in linear regression models, these 
differences remained significant for NDL-PCBs, DL-PCBs, cis-nonachlor, 
trans-nonachlor, HCB and p, p′-DDE (Table S5). 
We observed no significant positive associations between pre- 
diagnostic POP concentrations and incident T2DM after multivariable 
adjustments for confounding factors (Fig. 3). However, ɣ-HCH was 
inversely associated with T2DM. In contrast, we observed significant 
positive associations between post-diagnostic concentrations of trans- 
nonachlor, cis-nonachlor, and p,p′-DDE and prevalent T2DM (Fig. 3). 
Post-diagnostic ɣ-HCH concentrations remained negatively associated 
with T2DM. Using wet weight concentrations in the regression models 
gave similar results (Results not presented). 
All abovementioned results were similar in case-control group 2 that 
in addition to age, also was matched on BMI (results not shown). 
4. Discussion 
In this pilot study of pre- and post-diagnostic blood profiles in T2DM 
cases and controls, we observed significant differences in the direction 
and magnitude of longitudinal changes in lipid, hormone and POP 
concentrations between cases and controls. We observed no significant 
positive associations between pre-diagnostic POP concentrations and 
incident T2DM. However, several post-diagnostic POP concentrations 
were positively and significantly associated with prevalent T2DM. 
Overall, these results suggest that factors related to lifestyle changes 
after T2DM diagnosis, for instance changes in weight and lipid profiles 
may affect POP concentrations and subsequent associations between 
POPs and prevalent T2DM. 
Pre-diagnostic concentrations of several lipid-normalized POP con-
centrations were higher in cases compared to controls. However, after 
adjusting for confounding factors, the odds of developing T2DM in 
relation to elevated POP concentrations were non-significant, clearly 
emphasizing the role of BMI, lipids, weight change and diet as con-
founding factors in the POPs-T2DM association. Between the pre- and 
post-diagnostic blood sample collection, cases maintained a stable 
weight and developed a more favorable lipid profile (lower tri-
glycerides, lower total and LDL cholesterol, and higher HDL choles-
terol). In contrast, controls increased in weight, total lipids, and HDL 
cholesterol. The improvement in lipid profiles in cases is likely a result of 
a combination of lifestyle changes and use of diabetes medication 
following T2DM diagnosis. Overall, these results are supported by the 
findings of the National Health and Nutrition Examination Survey 
(NHANES) (Ford et al., 2013), in which T2DM cases improved their lipid 
profiles after diagnosis compared to healthy controls. In line with the 
improvement in lipid profiles, cases showed post-diagnostic FT4 con-
centrations that were higher than pre-diagnostic values. This observa-
tion is in accordance with the findings that FT4 concentrations are 
inversely correlated with triglyceride concentrations and positively 
correlated with HDL cholesterol concentrations (Roef et al., 2014). 
During that same time period, cases mainly experienced an increase in 
lipid-normalized concentrations of POPs (significantly for PCBs and 
HCB), except for β-HCH, which decreased, whereas controls experienced 
either a decrease or only a slight increase. One could expect a small 
decline in legacy POP concentrations in this period, due to past inter-
national regulations as reported in several blood monitoring studies 
(Nost et al., 2017; Thomsen et al., 2007; Vo et al., 2008). However, as 
our study period covers only 4 years and occurred several years after 
peak exposure, large differences in pre- and post-diagnostic POP con-
centrations were not expected. Overall, our findings suggest that the 
observed differences in longitudinal changes in lipid-normalized POP 
concentrations in cases compared to controls are largely affected by the 
improvements in lipid profiles in cases. Thus, a substantial decline in 
total lipid concentrations over a relatively short time period, concurrent 
with a relatively small natural decline in POP concentrations, may lead 
to artificially high POP concentrations, explaining the significant asso-
ciations between several post-diagnostic POPs and T2DM. These find-
ings are in line with several previous cross-sectional studies (Airaksinen 
et al., 2011; Lee et al., 2006; Rignell-Hydbom et al., 2009; Rylander 
et al., 2005; Ukropec et al., 2010) whereas our pre-diagnostic null results 
contradict those of several other prospective studies (Lee et al., 2011; 
Rignell-Hydbom et al., 2009; Turyk et al., 2015; Wu et al., 2013). 
However, there are also inconsistences across prospective studies, for 
instance about which POPs are positively associated with incident T2DM 
(Lee et al., 2011; Turyk et al., 2015; Wu et al., 2013; Zong et al., 2018). 
Blood sample collection also occurred in different calendar years, and 
the number of years between blood sample collection and T2DM diag-
nosis varies between studies. Thus, timing, in terms of both calendar 
year and time between blood sample collection and T2DM diagnosis, 
seems important to consider when comparing results from different 
prospective studies of POPs and T2DM. As pre-diabetes may be present 
long before clinical manifestation of the disease, factors related to T2DM 
may affect metabolic blood profiles years before T2DM diagnosis and 
induce disease progression bias in studies (Lee et al., 2014). Hence, there 
is clearly a need for longitudinal studies assessing pre-diagnostic con-
centrations of POPs repeated times prior to diagnosis as well as the ef-
fects of lifestyle changes and glucose-lowering medication on POP and 
lipid concentrations. We did, however, observe similar results in the 
case-control group matched on BMI and can conclude that matching by 
BMI seems unnecessary in future studies. 
To the best of our knowledge, this is the second published study of 
pre- and post-diagnostic measurements of POP concentrations in T2DM 
cases and controls; the first was published in 2019 and reported both 
similar and dissimilar results (Tornevi et al. 2019). Our study has a 
design that generates hypotheses that can be confirmed or refuted in 
future larger studies, and is unique as it includes information about a 
large number of metabolic factors in addition to POP concentrations. 
This pilot study was based on a relatively small sample size, thus we did 
not have sufficient power to draw firm conclusions based on all possible 
associations. However, we have sufficient sample size for detecting the 
longitudinal difference in concentrations for all the POPs, lipids and 
hormones (power >80% and the probability of committing a type 1 
error of 5%). 
5. Conclusions 
This pilot study suggests that factors related to T2DM affect blood 
concentrations of POPs and may partly explain the positive associations 
between POPs and prevalent T2DM. This pilot study highlight the 
importance of longitudinal studies with repeated measurements in order 
to critically assess whether the observed associations between POPs and 
T2DM actually reflect a causal mechanism. 
Authors’ contributions 
Vivian Berg: Conceptualization, Methodology, Formal analysis, 
Investigation, Writing – original draft, Funding acquisition; Dolley 
Charles: Conceptualization, Methodology, Investigation, Writing – 
original draft; Ingvar A Bergdahl: Methodology, Writing – review & 
editing; Therese H Nøst: Conceptualization, Writing – review & editing; 
Torkjel M Sandanger: Conceptualization, Writing – review & editing; 
Andreas Tornevi: Methodology, Writing – review & editing; Sandra 
Huber: Resources, Investigation, Writing – review & editing; Ole-Martin 
Fuskevåg: Resources, Investigation, Writing – review & editing; Char-
lotta Rylander: Conceptualization, Methodology, Writing – original 
draft, Project administration, Funding acquisition 
V. Berg et al.                                                                                                                                                                                                                                     
Environmental Research 195 (2021) 110846
6
Funding 
The project was financially supported by the Northern Norway 
Regional Health Authorities (project number: SFP1289) and Odd Bergs 
medical research fond. The funders had no influence on the design of the 
study. 
Ethics approval and consent to participate 
Participation in the NOWAC Study was voluntarily, and a signed 
consent form was obtained from all participants. The study was 
approved by the Regional Committee for Medical Research Ethics (REK, 
case number: 2015/1780). 
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgement 
We would like to thank the participants of the NOWAC Study for 
their willingness to participate and donate blood; Bente A. Augdal for 
preparing the samples; and Eiliv Lund for initiating, designing, and 
managing the NOWAC Study for many years. We also wish to thank the 
staff at the Department of Laboratory Medicine, University Hospital of 
North Norway, and especially Arnt R. Hagen, Tom Sollid, Julie S.K. 
Strømberg, Tone F. Aune, and Christina R. Hansen. 
List of abbreviations 
BMI body mass index 
CI confidence interval 
DAG directed acyclic graph 
DHEA-S Dehydroepiandrosterone sulfate 
DL-PCB Dioxin like polychlorinated biphenyl 
FT3 Free triiodothyronine 
FT4 Free thyroxin 
HCB Hexachlorobenzene 
HCH Hexachlorocyclohexane 
HDL High-density lipoprotein 
IQR Inter quartile range 
LDL Low-density lipoprotein 
LOD Limit of detection 
MRM Multiple reaction monitoring 
NDL-PCB Non-dioxin like polychlorinated biphenyl 
NOWAC Norwegian Women and Cancer study 
OCP Organochlorine Pesticides 
PCB Polychlorinated biphenyl 
POP Persistent Organic Pollutants 
p,p’-DDE 1,1-bis-(4-chlorophenyl)-2,2-dichloroethene 
p,p’-DDT 1,1,1-trichloro-2,2-bis-(4-chlorophenyl) ethane 
T2DM Type 2 Diabetes Mellitus 
TSH Thyroid-stimulating hormone 
OR Odds ratio 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.envres.2021.110846. 
References 
Accreditation, N., 2020. Accreditation scope for TEST 209 universitetssykehuset nord- 
norge HF laboratoriemedisin UNN. https://www.akkreditert.no/en/akkrediterte-or 
ganisasjoner/akkrediteringsomfang/?AkkId=577. (Accessed 27 February 2020). 
Airaksinen, R., Rantakokko, P., Eriksson, J.G., Blomstedt, P., Kajantie, E., Kiviranta, H., 
2011. Association between type 2 diabetes and exposure to persistent organic 
pollutants. Diabetes Care 34, 1972–1979. https://doi.org/10.2337/dc10-2303. 
De Roos, A.J., Ulrich, C.M., Sjodin, A., McTiernan, A., 2012. Adiposity, body 
composition, and weight change in relation to organochlorine pollutant plasma 
concentrations. J. Expo. Sci. Environ. Epidemiol. 22, 617–624. https://doi.org/ 
10.1038/jes.2012.43. 
Ford, E.S., Li, C., Sniderman, A., 2013. Temporal changes in concentrations of lipids and 
apolipoprotein B among adults with diagnosed and undiagnosed diabetes, 
prediabetes, and normoglycemia: findings from the National Health and Nutrition 
Examination Survey 1988-1991 to 2005-2008. Cardiovasc. Diabetol. 12, 26. https:// 
doi.org/10.1186/1475-2840-12-26. 
Huber, S., Averina, M., Brox, J., 2020. Automated sample preparation and GC-API-MS/ 
MS as powerful tool for analysis of legacy POPs in human serum and plasma. 
Analytical Methods. 
Hulsegge, G., Spijkerman, A.M.W., van der Schouw, Y.T., Bakker, S.J.L., Gansevoort, R. 
T., Smit, H.A., Verschuren, W.M.M., 2017. Trajectories of metabolic risk factors and 
biochemical markers prior to the onset of type 2 diabetes: the population-based 
longitudinal. Doetinchem study Nutr Diabetes 7, e270. https://doi.org/10.1038/ 
nutd.2017.23. 
Jansen, A., Lyche, J.L., Polder, A., Aaseth, J., Skaug, M.A., 2017. Increased blood levels 
of persistent organic pollutants (POP) in obese individuals after weight loss-A 
review. J. Toxicol. Environ. Health B Crit. Rev. 20, 22–37. https://doi.org/10.1080/ 
10937404.2016.1246391. 
Labquality, 2020. Labquality EQAS. https://www.labquality.fi/en/external-quality-ass 
essment/. (Accessed 16 January 2020). 
Lee, D.H., Lee, I.K., Song, K., Steffes, M., Toscano, W., Baker, B.A., Jacobs Jr., D.R., 2006. 
A strong dose-response relation between serum concentrations of persistent organic 
pollutants and diabetes: results from the National Health and Examination Survey 
1999-2002. Diabetes Care 29, 1638–1644. 
Lee, D.H., Lind, P.M., Jacobs Jr., D.R., Salihovic, S., van, B.B., Lind, L., 2011. 
Polychlorinated biphenyls and organochlorine pesticides in plasma predict 
development of type 2 diabetes in the elderly: the prospective investigation of the 
vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care 34, 1778–1784. 
https://doi.org/10.2337/dc10-2116. 
Lee, D.H., Porta, M., Jacobs Jr., D.R., Vandenberg, L.N., 2014. Chlorinated persistent 
organic pollutants. obesity, and type 2 diabetes Endocr Rev 35, 557–601. https:// 
doi.org/10.1210/er.2013-1084. 
Lund, E., Dumeaux, V., Braaten, T., Hjartaker, A., Engeset, D., Skeie, G., Kumle, M., 
2008. Cohort profile: the Norwegian women and cancer study–NOWAC–kvinner og 
kreft. Int. J. Epidemiol. 37, 36–41. https://doi.org/10.1093/ije/dym137. 
Nost, T.H., Sandanger, T.M., Nieboer, E., Odland, J.O., Breivik, K., 2017. The impacts of 
emission trends of POPs on human concentration dynamics: lessons learned from a 
longitudinal study in Norway (1979-2007). Int. J. Hyg Environ. Health 220, 
776–781. https://doi.org/10.1016/j.ijheh.2017.01.015. 
Phillips, D.L., Pirkle, J.L., Burse, V.W., Bernert, J.T., Henderson, L.O., Needham, L.L., 
1989. Chlorinated hydrocarbon levels in human serum. effects of fasting and feeding 
Archives of environmental contamination and toxicology 18, 495–500. 
Rignell-Hydbom, A., Lidfeldt, J., Kiviranta, H., Rantakokko, P., Samsioe, G., Agardh, C. 
D., Rylander, L., 2009. Exposure to p,p’-DDE: a risk factor for type 2 diabetes. PloS 
One 4, e7503. https://doi.org/10.1371/journal.pone.0007503. 
Roef, G.L., Rietzschel, E.R., Van Daele, C.M., Taes, Y.E., De Buyzere, M.L., Gillebert, T.C., 
Kaufman, J.-M., 2014. Triiodothyronine and free thyroxine levels are differentially 
associated with metabolic profile and adiposity-related cardiovascular risk markers 
in euthyroid middle-aged subjects. Thyroid 24, 223–231. 
Rylander, C., Sandanger, T.M., Engeset, D., Lund, E., 2014. Consumption of lean fish 
reduces the risk of type 2 diabetes mellitus: a prospective population based cohort 
study of Norwegian women. PloS One 9, e89845. https://doi.org/10.1371/journal. 
pone.0089845. 
Rylander, C., Sandanger, T.M., Nost, T.H., Breivik, K., Lund, E., 2015. Combining plasma 
measurements and mechanistic modeling to explore the effect of POPs on type 2 
diabetes mellitus in Norwegian women. Environ. Res. 142, 365–373. https://doi. 
org/10.1016/j.envres.2015.07.002. 
Rylander, L., Rignell-Hydbom, A., Hagmar, L., 2005. A cross-sectional study of the 
association between persistent organochlorine pollutants and diabetes. Environ. 
Health 4, 28. 
Thomaseth, K., Salvan, A., 1998. Estimation of occupational exposure to 2,3,7,8-tetra-
chlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model. Environ. 
Health Perspect. 106 (Suppl. 2), 743–753. https://doi.org/10.1289/ehp.98106743. 
Thomsen, C., Liane, V.H., Becher, G., 2007. Automated solid-phase extraction for the 
determination of polybrominated diphenyl ethers and polychlorinated biphenyls in 
serum–application on archived Norwegian samples from 1977 to 2003. 
J Chromatogr B Analyt Technol Biomed Life Sci 846, 252–263. https://doi.org/ 
10.1016/j.jchromb.2006.09.011. 
Tornevi, A., et al., 2019. Chlorinated persistent organic pollutants and type 2 diabetes - a 
population-based study with pre- and post- diagnostic plasma samples. Environ. Res. 
174, 35–45. https://doi.org/10.1016/j.envres.2019.04.017. 
Turyk, M., et al., 2015. Persistent organic pollutants and biomarkers of diabetes risk in a 
cohort of Great Lakes sport caught fish consumers. Environ. Res. 140, 335–344. 
https://doi.org/10.1016/j.envres.2015.03.037. 
V. Berg et al.                                                                                                                                                                                                                                     
Environmental Research 195 (2021) 110846
7
Ukropec, J., et al., 2010. High Prevalence of Prediabetes and Diabetes in a Population 
Exposed to High Levels of an Organochlorine Cocktail Diabetologia, vol. 53, 
pp. 899–906. https://doi.org/10.1007/s00125-010-1683-2. 
Vazquez, G., Duval, S., Jacobs Jr., D.R., Silventoinen, K., 2007. Comparison of body mass 
index, waist circumference, and waist/hip ratio in predicting incident diabetes: a 
meta-analysis. Epidemiol. Rev. 29, 115–128. https://doi.org/10.1093/epirev/ 
mxm008. 
Vo, T.T., Gladen, B.C., Cooper, G.S., Baird, D.D., Daniels, J.L., Gammon, M.D., 
Richardson, D.B., 2008. Dichlorodiphenyldichloroethane and polychlorinated 
biphenyls: intraindividual changes, correlations, and predictors in healthy women 
from the southeastern United States Cancer. Epidemiol Biomarkers Prev 17, 
2729–2736. https://doi.org/10.1158/1055-9965.EPI-08-0379. 
Wu, H., Bertrand, K.A., Choi, A.L., Hu, F.B., Laden, F., Grandjean, P., Sun, Q., 2013. 
Persistent organic pollutants and type 2 diabetes: a prospective analysis in the 
nurses’ health study and meta-analysis. Environ. Health Perspect. 121, 153–161. 
https://doi.org/10.1289/ehp.1205248. 
Waaseth, M., Bakken, K., Dumeaux, V., Olsen, K.S., Rylander, C., Figenschau, Y., 
Lund, E., 2008. Hormone replacement therapy use and plasma levels of sex 
hormones in the Norwegian Women and Cancer postgenome cohort - a cross- 
sectional analysis. BMC Wom. Health 8 (1). https://doi.org/10.1186/1472-6874-8- 
1. 
Zong, G., et al., 2018. Persistent organic pollutants and risk of type 2 diabetes: a 
prospective investigation among middle-aged women in Nurses’ Health Study II. 
Environ. Int. 114, 334–342. https://doi.org/10.1016/j.envint.2017.12.010. 
V. Berg et al.                                                                                                                                                                                                                                     
